JeffreyHSilberMD
Pediatric Hematology & Oncology • Philadelphia, PAProfessor, Pediatrics, Perelman School of Medicine
Are you Dr. Silber?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 60 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3401 Civic Center Blvd
Children's Hospital Of Philadelphia - Hem/Onc
Philadelphia, PA 19104Phone+1 215-590-3535Fax+1 215-590-3992- Is this information wrong?
Summary
- Dr. Jeffrey Silber, MD is a pediatric hematologist/oncologist in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania. He is a Professor at Perelman School of Medicine.
Education & Training
Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 1985 - 1988- Children's Hospital of PhiladelphiaResidency, Pediatrics, 1983 - 1988
Johns Hopkins University School of MedicineInternship, Transitional Year, 1980 - 1981- Johns Hopkins University School of MedicineClass of 1980
Certifications & Licensure
PA State Medical License 1982 - 2024- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Enalapril After Anthracycline Cardiotoxicity Start of enrollment: 1994 Apr 01
Publications & Presentations
PubMed
- 2 citationsDefining Multimorbidity in Older Patients Hospitalized with Medical Conditions.Siddharth Jain, Paul R Rosenbaum, Joseph G Reiter, Omar I Ramadan, Alexander S Hill, Sean Hashemi, Rebecca T Brown, Rachel R Kelz, Lee A Fleisher, Jeffrey H Silber> ;Journal of General Internal Medicine. 2023 May 1
- 2 citationsEmerging approaches to multiple chronic condition assessment.Jerry Suls, Marcel E Salive, Siran M Koroukian, Farrokh Alemi, Jeffrey H Silber, Gabi Kastenmüller, Carrie N Klabunde> ;Journal of the American Geriatrics Society. 2022 Sep 1
- Risk of Parkinson's disease after anaesthesia and surgery.Siddharth Jain, Paul R Rosenbaum, Joseph G Reiter, Alexander S Hill, David A Wolk, Sean Hashemi, Lee A Fleisher, Roderic Eckenhoff, Jeffrey H Silber> ;British Journal of Anaesthesia. 2022 Apr 1
- Join now to see all
Press Mentions
- New Definitions of Multimorbidity May Improve Clinical Decision-Making for Older Surgical PatientsMarch 15th, 2023
High-Risk Surgical Patients Benefit from Teaching HospitalsNovember 13th, 2019
Racial Disparities in Colon Cancer Survival PersistDecember 30th, 2018- Join now to see all
Grant Support
- A Pediatric Quality Measurement Center And Testing LaboratoryAgency For Healthcare Research And Quality2011–2012
- Pediatric Hospital Epidemiology And Outcomes Research Training (PHEOT) ProgramEunice Kennedy Shriver National Institute Of Child Health &Human Development2010–2012
- Improving Process MeasurementAgency For Healthcare Research And Quality2010–2012
- Understanding Racial Disparities In Surgical OutcomesNational Institute On Aging2009–2011
- Describing And Understanding Racial DisparitiesAgency For Healthcare Research And Quality2009–2011
- Obesity And Surgical OutcomesNational Institute Of Diabetes And Digestive And Kidney Diseases2006–2010
- Provider Specialty And Outcomes In Ovarian CancerNational Cancer Institute2004–2005
- Provider Specialty And Outcomes In Ovarian CancerNational Cancer Institute2003
- Economic Evaluation Of Fever Management In Children With Sickle Cell DiseaseNational Heart, Lung, And Blood Institute1998–2002
- Enalapril After Anthracycline CardiotoxicityNational Center For Research Resources1995–2002
- Conditional Length Of Stay: A Pediatrics Outcome MeasureAgency For Healthcare Research And Quality2000–2001
- Surgical Outcome Rates: Identifying Etiologic FactorsAgency For Healthcare Research And Quality1999–2000
- Conditional Length Of Stay--A Pediatrics Outcome MeasureAgency For Healthcare Research And Quality1999
- Surgical Outcome Rates--Identifying Etiologic FactorsAgency For Healthcare Research And Quality1998
- Enalapril After Anthracycline CardiotoxicityNational Heart, Lung, And Blood Institute1994–1998
- Failure Rate: A New Outcome Measure Of Quality Of CareAgency For Healthcare Research And Quality1992–1993
- Prediction And Outcome Measurement In Childhood CancerNational Cancer Institute1989–1993
